Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Int J Bacteriol
2014 Jan 01;2014:481686. doi: 10.1155/2014/481686.
Show Gene links
Show Anatomy links
Activity of Aristolochia bracteolata against Moraxella catarrhalis.
Suliman Mohamed M
,
Timan Idriss M
,
Khedr AI
,
Abd AlGadir H
,
Takeshita S
,
Shah MM
,
Ichinose Y
,
Maki T
.
???displayArticle.abstract???
A bioassay-guided fractionation of methanol extract of Aristolochia bracteolata whole plant was carried out in order to evaluate its antimicrobial activity and to identify the active compounds in this extract. Antibacterial and antifungal activities of methanol extract against gram-positive, gram-negative, and fungal strains were investigated by the agar disk diffusion method. Among the strains tested, Moraxella catarrhalis and sea urchin-derived Bacillus sp. showed the highest sensitivity towards the methanol extract and hence they are used as test organisms for the bioassay-guided fractionation. From this extract, aristolochic acid 1 (AA-1) has been isolated and has showed the greatest antibacterial activity against both standard strain and clinical isolates of Moraxella catarrhalis with equal minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) values of 25 and 50 μg/mL. Modification of the AA-1 to AA-1 methyl ester completely abolished the antibacterial activity of the compound and the piperonylic acid moiety of AA-1 which suggested that the coexistence of phenanthrene ring and free carboxylic acid is essential for AA-1 antibacterial activity.
Abdullah,
Prevalence and emerging resistance of Moraxella catarrhalis in lower respiratory tract infections in Karachi.
2013, Pubmed
Abdullah,
Prevalence and emerging resistance of Moraxella catarrhalis in lower respiratory tract infections in Karachi.
2013,
Pubmed
Catlin,
Branhamella catarrhalis: an organism gaining respect as a pathogen.
1990,
Pubmed
Chitme,
Antiallergic activity of Aristolochia bracteolata Lank in animal model.
2010,
Pubmed
Cowan,
Plant products as antimicrobial agents.
1999,
Pubmed
Debelle,
Aristolochic acid nephropathy: a worldwide problem.
2008,
Pubmed
Del Beccaro,
Bacteriology of acute otitis media: a new perspective.
1992,
Pubmed
El-Tahir,
Antiplasmodial activity of selected sudanese medicinal plants with emphasis on Acacia nilotica.
1999,
Pubmed
Gillerot,
Aristolochic acid nephropathy in a Chinese patient: time to abandon the term "Chinese herbs nephropathy"?
2001,
Pubmed
Heinrich,
Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2--a global assessment based on bibliographic sources.
2009,
Pubmed
Hoang,
Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing.
2013,
Pubmed
Karalus,
Moraxella catarrhalis: a review of an important human mucosal pathogen.
2000,
Pubmed
Katiyar,
Drug discovery from plant sources: An integrated approach.
2012,
Pubmed
McGregor,
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
1998,
Pubmed
Nweze,
Agar-based disk diffusion assay for susceptibility testing of dermatophytes.
2010,
Pubmed
Perez,
Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo.
2014,
Pubmed
Poon,
Genome-wide mutational signatures of aristolochic acid and its application as a screening tool.
2013,
Pubmed
Verduin,
Moraxella catarrhalis: from emerging to established pathogen.
2002,
Pubmed